ti.\*:("Novel molecules and mechanisms in critical care medicine")
Results 1 to 11 of 11
Selection :
Novel molecules and mechanisms in critical care medicineLIPSETT, Pamela; WONG, Hector R.Critical care medicine. 2002, Vol 30, Num 1, issn 0090-3493, 97 p., SUPSerial Issue
Toll-like receptorsLIEN, Egil; INGALLS, Robin R.Critical care medicine. 2002, Vol 30, Num 1, pp S1-S11, issn 0090-3493, SUPArticle
Endotoxin tolerance: A reviewWEST, Michael A; HEAGY, Wyrta.Critical care medicine. 2002, Vol 30, Num 1, pp S64-S73, issn 0090-3493, SUPArticle
Carbon monoxide-dependent signalingMORSE, Danielle; SETHI, Jigme; CHOI, Augustine M. K et al.Critical care medicine. 2002, Vol 30, Num 1, pp S12-S17, issn 0090-3493, SUPArticle
Macrophage migration inhibitory factorBAUGH, John A; BUCALA, Richard.Critical care medicine. 2002, Vol 30, Num 1, pp S27-S35, issn 0090-3493, SUPArticle
Mitogen-activated protein kinasesARBABI, Saman; MAIER, Ronald V.Critical care medicine. 2002, Vol 30, Num 1, pp S74-S79, issn 0090-3493, SUPArticle
The IKK/NF-κB pathwaySENFTLEBEN, Uwe; KARIN, Michael.Critical care medicine. 2002, Vol 30, Num 1, pp S18-S26, issn 0090-3493, SUPArticle
Phosphatases: Counterregulatory role in inflammatory cell signalingSHANLEY, Thomas P.Critical care medicine. 2002, Vol 30, Num 1, pp S80-S88, issn 0090-3493, SUPArticle
Functional genomics of critical illness and injuryCHUNG, T. Philip; LARAMIE, Jason M; PROVINCE, Michael et al.Critical care medicine. 2002, Vol 30, Num 1, pp S51-S57, issn 0090-3493, SUPArticle
High-mobility group-I/Y proteins: Potential role in the pathophysiology of critical illnessesCARVAJAL, Irvith M; BARON, Rebecca M; PERRELLA, Mark A et al.Critical care medicine. 2002, Vol 30, Num 1, pp S36-S42, issn 0090-3493, SUPArticle
Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drugOBERHOLZER, Andreas; OBERHOLZER, Caroline; MOLDAWER, Lyle L et al.Critical care medicine. 2002, Vol 30, Num 1, pp S58-S63, issn 0090-3493, SUPArticle